Nanjing Kangmanlin Chemical industry Co., Ltd. sincerely invites you to attend the 2026 Shanghai New International Expo Centre Chemical Exhibition. Our booth number is W4C52,, we willcomprehensively showcase our latest product line, technological innovation achievements, andcustomized solutions at this exhibition, covering multiple fields such as fine chemicals,environmentally friendly materials, and industrial additives.

Recently, Chemlin Biopharmaceutical Company has made a series of significant breakthroughs in drug research and development, successfully launching multiple innovative drugs covering multiple treatment areas such as cancer, rare diseases, and chronic diseases. These achievements not only mark the company's leading position in biopharmaceutical technology, but also bring new treatment options and hope to patients worldwide.

Recently, Professor Zhang Guoqing's team from the National Research Center for Microscale Matter Science at the University of Science and Technology of China in Hefei reported the discovery of a new mode of interaction between organic molecules: a stable photo induced charge transfer complex can be formed between aromatic imides and fatty amines. The properties and formation process of this complex were systematically studied through steady-state and time-resolved emission spectroscopy, absorption spectroscopy, mass spectrometry, paramagnetic resonance spectroscopy, and other methods. It was demonstrated that this complex can be used in fields such as photo induced polymerization, carbon dioxide photoreduction, and ultraviolet energy storage. The achievement was published in Chem under the title "Trapping Highly Reactive Photo Induced Charge Transfer Complex Between Amine and Imide by Light".

Recently, Chemlin Biopharmaceutical Company, as an industry leader, made a grand appearance at the 2023 International Biopharmaceutical Exhibition, becoming the focus of attention from the audience.